Tang Mitosis/Apoptosis ver. II - Dataset (ID:20003)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | Cell Line | Assay compound conc (uM) | Day | Image | Cell count | Interphase count | Apoptotic count | Dead count | Mitotic count | % Interphase | % Apoptotic | % Mitotic | Recorded Plate | Recorded Well | Control Type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MLN8054 | PE/CA-PJ15 | 0.00056 | 3 | | 3572 | 3378 | 81 | 0 | 113 | 94.57 | 2.27 | 3.16 | 6 | I10 | |
| PE/CA-PJ15 | 1 | | 1117 | 1066 | 14 | 1 | 36 | 95.43 | 1.34 | 3.22 | 6 | I11 | N | ||
| PE/CA-PJ15 | 2 | | 1903 | 1797 | 36 | 0 | 70 | 94.43 | 1.89 | 3.68 | 6 | I11 | N | ||
| PE/CA-PJ15 | 3 | | 3583 | 3402 | 71 | 0 | 110 | 94.95 | 1.98 | 3.07 | 6 | I11 | N | ||
| MLN8054 | PE/CA-PJ15 | 0.00056 | 1 | | 1143 | 1069 | 26 | 2 | 46 | 93.53 | 2.45 | 4.02 | 6 | I12 | |
| MLN8054 | PE/CA-PJ15 | 0.00056 | 2 | | 2049 | 1932 | 37 | 0 | 80 | 94.29 | 1.81 | 3.90 | 6 | I12 | |
| MLN8054 | PE/CA-PJ15 | 0.00056 | 3 | | 3485 | 3296 | 79 | 0 | 110 | 94.58 | 2.27 | 3.16 | 6 | I12 | |
| Tozasertib | PE/CA-PJ15 | 0.412 | 1 | | 591 | 536 | 15 | 11 | 29 | 90.69 | 4.40 | 4.91 | 6 | I13 | |
| Tozasertib | PE/CA-PJ15 | 0.412 | 2 | | 831 | 771 | 27 | 6 | 27 | 92.78 | 3.97 | 3.25 | 6 | I13 | |
| Tozasertib | PE/CA-PJ15 | 0.412 | 3 | | 908 | 822 | 69 | 1 | 16 | 90.53 | 7.71 | 1.76 | 6 | I13 | |
| PE/CA-PJ15 | 1 | | 965 | 900 | 29 | 3 | 33 | 93.26 | 3.32 | 3.42 | 6 | I14 | N | ||
| PE/CA-PJ15 | 2 | | 1946 | 1848 | 40 | 0 | 58 | 94.96 | 2.06 | 2.98 | 6 | I14 | N | ||
| PE/CA-PJ15 | 3 | | 3634 | 3483 | 46 | 0 | 105 | 95.85 | 1.27 | 2.89 | 6 | I14 | N | ||
| Tozasertib | PE/CA-PJ15 | 0.412 | 1 | | 640 | 600 | 11 | 6 | 23 | 93.75 | 2.66 | 3.59 | 6 | I15 | |
| Tozasertib | PE/CA-PJ15 | 0.412 | 2 | | 910 | 862 | 24 | 1 | 23 | 94.73 | 2.75 | 2.53 | 6 | I15 | |
| Tozasertib | PE/CA-PJ15 | 0.412 | 3 | | 829 | 744 | 67 | 2 | 16 | 89.75 | 8.32 | 1.93 | 6 | I15 | |
| GSK1070916 | PE/CA-PJ15 | 0.412 | 1 | | 733 | 677 | 18 | 6 | 32 | 92.36 | 3.27 | 4.37 | 6 | I16 | |
| GSK1070916 | PE/CA-PJ15 | 0.412 | 2 | | 897 | 850 | 25 | 8 | 14 | 94.76 | 3.68 | 1.56 | 6 | I16 | |
| GSK1070916 | PE/CA-PJ15 | 0.412 | 3 | | 1120 | 1011 | 94 | 0 | 15 | 90.27 | 8.39 | 1.34 | 6 | I16 | |
| Tozasertib | PE/CA-PJ15 | 0.00056 | 1 | | 964 | 920 | 12 | 7 | 25 | 95.44 | 1.97 | 2.59 | 6 | I17 | |
| Tozasertib | PE/CA-PJ15 | 0.00056 | 2 | | 1769 | 1647 | 43 | 20 | 59 | 93.10 | 3.56 | 3.34 | 6 | I17 | |
| Tozasertib | PE/CA-PJ15 | 0.00056 | 3 | | 3374 | 3230 | 61 | 0 | 83 | 95.73 | 1.81 | 2.46 | 6 | I17 | |
| GSK1070916 | PE/CA-PJ15 | 0.412 | 1 | | 722 | 678 | 18 | 5 | 21 | 93.91 | 3.19 | 2.91 | 6 | I18 | |
| GSK1070916 | PE/CA-PJ15 | 0.412 | 2 | | 973 | 916 | 28 | 11 | 18 | 94.14 | 4.01 | 1.85 | 6 | I18 | |
| GSK1070916 | PE/CA-PJ15 | 0.412 | 3 | | 1051 | 966 | 75 | 0 | 10 | 91.91 | 7.14 | 0.95 | 6 | I18 |